Table 1. The link between NLRC5 protein levels and clinical characteristic of HCC patients.
| Clinical characteristic | Number | NLRC5 | χ2 | P | |
|---|---|---|---|---|---|
| Positive | Negative | ||||
| Age (year) | 0.003 | 0.584 | |||
| ≤60 | 27 | 17 | 10 | ||
| >60 | 33 | 21 | 12 | ||
| Gender | 0.028 | 0.542 | |||
| Male | 39 | 25 | 14 | ||
| Female | 21 | 13 | 8 | ||
| Cirrhosis | 3.603 | 0.015 | |||
| With | 44 | 32 | 12 | ||
| Without | 16 | 6 | 10 | ||
| Tumor size (cm) | 1.279 | 0.194 | |||
| ≤5 | 27 | 15 | 12 | ||
| >5 | 33 | 23 | 10 | ||
| Number of tumors | 0.096 | 0.506 | |||
| Single | 45 | 28 | 17 | ||
| Multiple | 15 | 10 | 5 | ||
| Differentiation degree | 2.453 | 0.293 | |||
| High | 11 | 5 | 6 | ||
| Medium | 33 | 21 | 12 | ||
| Low | 16 | 12 | 4 | ||
| TNM stage | 6.969 | 0.011 | |||
| I+II | 39 | 20 | 19 | ||
| III+IV | 21 | 18 | 3 | ||
NLRC5, NLR family CARD domain containing 5; HCC, hepatocellular carcinoma.